ConductScience.org, home

Paper35451676

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory.

Ellingson BM and 2 others. Neurotherapeutics, 2022. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory. Papers, record 35451676. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35451676

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory.
PubMed
Journal
Neurotherapeutics
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.16
iCite
Revised in PubMed
2024-02-04
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ellingson BMBenjamin Mhttps://orcid.org/0000-0002-2764-6640
2Levin VAVictor A
3Cloughesy TFTimothy F

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GliomaMajor topic
Brain NeoplasmsMajor topic
Humans
Systems Theory
Magnetic Resonance Imaging
Brain
Drug Combinations

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA211015NCI NIH HHSUnited StatesP50CA211015PubMedNIH RePORTER
R01 CA270027NCI NIH HHSUnited StatesR01CA270027PubMed and NIHNIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18478956Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.J Natl Cancer Inst1993https://conductscience.org/library/papers/8478956PubMed
230652553Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.JCO Clin Cancer Inform2018https://conductscience.org/library/papers/30652553PubMed
327580889Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.Neuro Oncol2017https://conductscience.org/library/papers/27580889PubMed
425672376Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.Int J Oncol2015https://conductscience.org/library/papers/25672376PubMed
532048719Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.Neuro Oncol2020https://conductscience.org/library/papers/32048719PubMed
618847342Independent association of extent of resection with survival in patients with malignant brain astrocytoma.J Neurosurg2009https://conductscience.org/library/papers/18847342PubMed
721979382FSL.Neuroimage2012https://conductscience.org/library/papers/21979382PubMed
83385495A selective impairment of motion perception following lesions of the middle temporal visual area (MT).J Neurosci1988https://conductscience.org/library/papers/3385495PubMed
915501092Advances in functional and structural MR image analysis and implementation as FSL.Neuroimage2004https://conductscience.org/library/papers/15501092PubMed
10894339Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors.J Neurosurg1977https://conductscience.org/library/papers/894339PubMed
1128718326CNS Anticancer Drug Discovery and Development: 2016 conference insights.CNS Oncol2017https://conductscience.org/library/papers/28718326PubMed
1229040703Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma.Neuro Oncol2018https://conductscience.org/library/papers/29040703PubMed
1330258190Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients.Sci Rep2018https://conductscience.org/library/papers/30258190PubMed
1428108885Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Neurotherapeutics2017https://conductscience.org/library/papers/28108885PubMed
153339397The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.J Clin Oncol1988https://conductscience.org/library/papers/3339397PubMed
161332459MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences.AJNR Am J Neuroradiol1992https://conductscience.org/library/papers/1332459PubMed
1726250565Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.Neuro Oncol2015https://conductscience.org/library/papers/26250565PubMed
1823983030The role of human ventral visual cortex in motion perception.Brain2013https://conductscience.org/library/papers/23983030PubMed
1924475840Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.Radiology2014https://conductscience.org/library/papers/24475840PubMed
203033172Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.J Neurosurg1987https://conductscience.org/library/papers/3033172PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
38808755Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors.Neuro Oncol2024https://conductscience.org/library/papers/38808755PubMed
36344725Therapeutic Advances in Neuro-Oncology.Neurotherapeutics2022https://conductscience.org/library/papers/36344725PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FASTK10922PubTator's text mininghttps://conductscience.org/library/genes/10922NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35451676

GET https://conductscience.org/api/papers/v1/35451676/references?page=2